Researchers Submit Patent Application, "Compositions And Methods For Treatment Of Bleeding Disorders", for Approval (USPTO 20240002861).

Band Therapeutics LLC has submitted a patent application to the US Patent and Trademark Office for a method of treating bleeding disorders, such as hemophilia A and von Willebrand disease (VWD). The application describes the use of VWF targeting agents, specifically VWF binding aptamers like BT200, to increase the circulatory level of VWF and extend the circulatory life of FVIII. These agents can be administered in different doses and in combination with other treatments. The patent application provides detailed claims and methods for administering the composition, offering potential therapeutic options for patients with bleeding disorders. [Extracted from the article]

Copyright of Hematology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)